Showing results (861-870 of 36,470) with videos related to

Sort By:
Pageof 3,647
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Frontiers in Oncology|March 25, 2021
Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?Brandon Douglas Brown, Francesco Paolo Tambaro, Mira Kohorst, et al.
Frontiers in Oncology|November 4, 2021
Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma PeritoneiLei Liang, Jingyang Fang, Xuedi Han, et al.
Frontiers in Oncology|November 4, 2021
Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the ChallengesWanru Zhang, Yaping An, Xiali Qin, et al.
Frontiers in Oncology|November 4, 2021
The Impact of Diabetes on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Systematic Review and Meta-AnalysisXiaoshuai Gao, Liang Zhou, Jianzhong Ai, et al.
Frontiers in Oncology|November 4, 2021
Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell CarcinomaHong Liu, Ruiyi Xu, Chun Gao, et al.
Frontiers in Oncology|November 11, 2021
Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain MetastasesXiaoyu Zhi, Jiancheng Luo, Weiwei Li, et al.
Frontiers in Oncology|November 11, 2021
Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An UpdateKavitha Unnikrishnan, Lynda Velutheril Thomas, Ram Mohan Ram Kumar
Frontiers in Oncology|November 11, 2021
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon CancerAmr Mohamed, Renjian Jiang, Philip A Philip, et al.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Pageof 3,647